CD4 and neoplasm: Notably, recent studies of MHC-I-restricted TCRs recognizing tumor antigens with a similar range of tetramer-binding capacity to those in our study did observe a correlation between TCR avidity and T cell functions in vitro and in vivo, suggesting that the possibility that CD4+ and CD8+ T cell subsets and their respective functions have different TCR avidity requirements18,30.